115 related articles for article (PubMed ID: 38258494)
1. Nucleosome assembly protein 1-like 1 (NAP1L1) in gastric cancer patients: a potential biomarker with diagnostic and prognostic utility.
Gul G; Aydin MA; Algul S; Kiziltan R; Kemik O
Biomarkers; 2024 Feb; 29(1):30-35. PubMed ID: 38258494
[TBL] [Abstract][Full Text] [Related]
2. Nucleosome assembly protein 1-like 1 (NAP1L1) in colon cancer patients: a potential biomarker with diagnostic and prognostic utility.
Aydin MA; Gul G; Kiziltan R; Algul S; Kemik O
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10512-10517. PubMed ID: 33155206
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma.
Nagashio R; Kuchitsu Y; Igawa S; Kusuhara S; Naoki K; Satoh Y; Ichinoe M; Murakumo Y; Saegusa M; Sato Y
Biomed Res; 2020; 41(3):149-159. PubMed ID: 32522932
[TBL] [Abstract][Full Text] [Related]
4. NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer.
Xiaohua Zhu ; Xie Y; Huang W; Chen Z; Guo S
BMC Cancer; 2022 Mar; 22(1):339. PubMed ID: 35351053
[TBL] [Abstract][Full Text] [Related]
5. KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription.
Gupta N; Thakker S; Verma SC
Sci Rep; 2016 Sep; 6():32633. PubMed ID: 27599637
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus NS5A Targets Nucleosome Assembly Protein NAP1L1 To Control the Innate Cellular Response.
Çevik RE; Cesarec M; Da Silva Filipe A; Licastro D; McLauchlan J; Marcello A
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659470
[No Abstract] [Full Text] [Related]
7. NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma.
Le Y; Kan A; Li QJ; He MK; Chen HL; Shi M
Cancer Cell Int; 2019; 19():228. PubMed ID: 31516385
[TBL] [Abstract][Full Text] [Related]
8. Nucleosome Assembly Protein 1-Like 1 (Nap1l1) Regulates the Proliferation of Murine Induced Pluripotent Stem Cells.
Yan Y; Yin P; Gong H; Xue Y; Zhang G; Fang B; Chen Z; Li Y; Yang C; Huang Z; Yang X; Ge J; Zou Y
Cell Physiol Biochem; 2016; 38(1):340-50. PubMed ID: 26824453
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of nucleosome assembly protein 1-like 1 induces mesoderm formation and cardiomyogenesis via notch signaling in murine-induced pluripotent stem cells.
Gong H; Yan Y; Fang B; Xue Y; Yin P; Li L; Zhang G; Sun X; Chen Z; Ma H; Yang C; Ding Y; Yong Y; Zhu Y; Yang H; Komuro I; Ge J; Zou Y
Stem Cells; 2014 Jul; 32(7):1759-73. PubMed ID: 24648372
[TBL] [Abstract][Full Text] [Related]
10. NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun.
Chen Z; Xie Y; Luo H; Song Y; Que T; Hu R; Huang H; Luo K; Li C; Qin C; Zheng C; Fang W; Liu L; Long H; Luo Q
Aging (Albany NY); 2021 Dec; 13(24):26180-26200. PubMed ID: 34959221
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis.
Huang Y; Xiang B; Liu Y; Wang Y; Kan H
Cancer Lett; 2018 Nov; 437():56-66. PubMed ID: 30165194
[TBL] [Abstract][Full Text] [Related]
12. The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.
Kidd M; Modlin IM; Mane SM; Camp RL; Eick G; Latich I
Ann Surg Oncol; 2006 Feb; 13(2):253-62. PubMed ID: 16424981
[TBL] [Abstract][Full Text] [Related]
13. NAP1L1: A Novel Human Colorectal Cancer Biomarker Derived From Animal Models of
Queiroz CJS; Song F; Reed KR; Al-Khafaji N; Clarke AR; Vimalachandran D; Miyajima F; Pritchard DM; Jenkins JR
Front Oncol; 2020; 10():1565. PubMed ID: 32850460
[TBL] [Abstract][Full Text] [Related]
14. Nap1l1 Controls Embryonic Neural Progenitor Cell Proliferation and Differentiation in the Developing Brain.
Qiao H; Li Y; Feng C; Duo S; Ji F; Jiao J
Cell Rep; 2018 Feb; 22(9):2279-2293. PubMed ID: 29490266
[TBL] [Abstract][Full Text] [Related]
15. Nucleosome assembly proteins NAP1L1 and NAP1L4 modulate p53 acetylation to regulate cell fate.
Tanaka T; Hozumi Y; Martelli AM; Iino M; Goto K
Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118560. PubMed ID: 31634504
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
18. A New Role of NAP1L1 in Megakaryocytes and Human Platelets.
Freitag M; Schwertz H
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499021
[TBL] [Abstract][Full Text] [Related]
19. NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.
Liu S; Zhang Y; Cui S; Song D; Li B; Chen Q; Yao G; Gong B
Cancer Cell Int; 2021 Nov; 21(1):605. PubMed ID: 34774047
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.
Hur H; Yu EJ; Ham IH; Jin HJ; Lee D
Oncotarget; 2017 Feb; 8(7):10994-11003. PubMed ID: 28036255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]